VTv Total Stockholder Equity from 2010 to 2024
| VTVT Stock | USD 14.18 0.65 4.38% |
Total Stockholder Equity | First Reported 2014-03-31 | Previous Quarter 16.5 M | Current Value 15 M | Quarterly Volatility 81.1 M |
Check VTv Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VTv Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 85.5 K, Interest Expense of 12.3 K or Selling General Administrative of 11.5 M, as well as many indicators such as Price To Sales Ratio of 27.56, Dividend Yield of 0.0 or Days Sales Outstanding of 2 K. VTv financial statements analysis is a perfect complement when working with VTv Therapeutics Valuation or Volatility modules.
VTv | Total Stockholder Equity |
Latest VTv Therapeutics' Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of vTv Therapeutics over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. VTv Therapeutics' Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VTv Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
VTv Total Stockholder Equity Regression Statistics
| Arithmetic Mean | (154,450,133) | |
| Coefficient Of Variation | (97.02) | |
| Mean Deviation | 125,531,644 | |
| Median | (82,853,000) | |
| Standard Deviation | 149,842,841 | |
| Sample Variance | 22452.9T | |
| Range | 489.1M | |
| R-Value | 0.81 | |
| Mean Square Error | 8386.6T | |
| R-Squared | 0.65 | |
| Significance | 0.0003 | |
| Slope | 27,078,879 | |
| Total Sum of Squares | 314340.3T |
VTv Total Stockholder Equity History
About VTv Therapeutics Financial Statements
VTv Therapeutics shareholders use historical fundamental indicators, such as Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although VTv Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in VTv Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on VTv Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | -24.7 M | -25.9 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VTv Stock Analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.